Kolexia
Blanc Jean-Frederic Gastro-entérologie
Blanc Jean-Frederic
Gastro-entérologie
Hôpital Saint-André
Bordeaux, France
327 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome hépatocellulaire Carcinomes Tumeurs du foie Adénocarcinome Tumeurs du pancréas Cirrhose du foie Fibrose Adénome hépatocellulaire Adénomes

Collaborateurs

Voir plus
Merle Philippe
Merle Philippe
Hôpital La Croix-Rousse, Lyon, France
Assenat Eric
Assenat Eric
Icm Montpellier, Montpellier, France
Edeline Julien
Edeline Julien
Centre Eugène Marquis, Rennes, France
Bioulac Paulette
Bioulac Paulette
Hôpital Pellegrin, Bordeaux, France

Industries

Voir plus
Ipsen
72 collaboration(s)
Dernière en 2023
Servier
32 collaboration(s)
Dernière en 2023
Roche
27 collaboration(s)
Dernière en 2023
AstraZeneca
27 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LAP-NET1: Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
Essai Clinique (NETRIS Pharma)   07 mars 2024
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Liver international : official journal of the International Association for the Study of the Liver   04 mars 2024
PROACTIF: A Prospective, Post Approval, Multiple Centre, Open-Label, Non-Interventional, Registry Study to Evaluate Effectiveness of TheraSphere® in Clinical Practice in France
Essai Clinique (Boston Scientific)   21 février 2024
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level Amplification: Preclinical and Clinical Evidence.
JCO precision oncology   16 février 2024
THBS1 myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1.
Cell reports   12 février 2024
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
European journal of cancer (Oxford, England : 1990)   06 février 2024
GEMOXIA-02: Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma: a Multicentric Single-arm Phase II Study
Essai Clinique (CHU Montpellier)   15 janvier 2024
IMMUNO-BIL: Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy: a Randomized Non-comparative Two-arm Phase II Study
Essai Clinique (AstraZeneca)   03 janvier 2024
RP3 in Combination With 1L or 2L Therapy in Patients With Locally Advanced Unresectable or Metastatic HCC: A Phase 2, Open-label, Multicenter Study Investigating RP3 Oncolytic Immunotherapy in Combination With First- or Second-line Therapy in Patients With Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma
Essai Clinique (Replimune Inc.)   21 décembre 2023
Efficacy of Selective Internal Radiation Therapy for Hepatocellular Carcinoma Post-Incomplete Response to Chemoembolization.
Pharmaceuticals (Basel, Switzerland)   01 décembre 2023